Le Lézard
Classified in: Covid-19 virus
Subject: Webcast

Retractable Technologies, Inc. to Host Virtual Annual Meeting of Shareholders


Retractable Technologies, Inc. (NYSE American: RVP) (the "Company") today announced that, due to the public health impact of the coronavirus (COVID-19) pandemic, and related health and travel concerns, the adjourned 2020 annual meeting of shareholders of Retractable Technologies, Inc. (the "Annual Meeting") has been changed to a virtual-only format via live webcast. As previously announced, the Annual Meeting will be held on June 22, 2020 at 10:00 a.m. Central time. Shareholders will not be able to attend the Annual Meeting in person.

Shareholders are entitled to participate in the live webcast of the Annual Meeting if they held shares of the Company as of the close of business on March 13, 2020, the record date. Such shareholders will be able to participate by visiting www.virtualshareholdermeeting.com/RVP2020 and entering the 16-digit control number found on the voting form that was enclosed with the previously-distributed proxy materials for the Annual Meeting. Online access will open shortly prior to the start of the Annual Meeting to allow time to log in.

A notice regarding the change to the format of the Annual Meeting (the "Notice") is being filed with the Securities and Exchange Commission together with this press release.

About Retractable Technologies, Inc.

The Company manufactures and markets VanishPoint® and Patient Safe® safety medical products and the EasyPoint® needle. The VanishPoint® syringe, blood collection, and IV catheter products are designed to prevent needlestick injuries and product reuse by retracting the needle directly from the patient, effectively reducing exposure to the contaminated needle. Patient Safe® syringes are uniquely designed to reduce the risk of bloodstream infections resulting from catheter hub contamination. The EasyPoint® is a retractable needle that can be used with luer lock syringes, luer slip syringes, and prefilled syringes to give injections. The EasyPoint® needle also can be used to aspirate fluids and for blood collection. The Company's products are distributed by various specialty and general line distributors.

For more information on Retractable Technologies, Inc., visit its website at www.retractable.com.


These press releases may also interest you

at 02:35
SpikImm Announces the Signature of an Exclusive License Option and Collaboration Agreement With SATT Conectus for the Development of a Prophylactic Treatment Against the BK Virus, Causing Severe Complications in Transplant Patients
SpikImm, a clinical-stage biotechnology company founded in 2021 by Truffle Capital in collaboration with Institut Pasteur and dedicated to the development of monoclonal antibodies to prevent viral infections in immunocompromised patients, today...

at 02:25
FPT Commits to Sustainable Development, Aligning with ESG Standards
As part of its ongoing commitment to the highest standards of sustainable development, FPT Corporation (FPT) has published its ESG report and prioritized ESG as a key aspect of its 2024 development strategy. The report highlights FPT's achievement of...

at 02:00
SSI Schaefer & Noatum Logistics: Success of the Largest Mobile Racking System Installation for Cold Rooms in the UAE
SSI Schaefer, a global leader in warehouse automation and cold-chain storage solutions, is announcing the results of its partnership with Noatum Logistics Middle East, an integrated regional end-to-end logistics services arm of Noatum, an AD...

15 avr 2024
QDEL INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that QuidelOrtho Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit!
Attorney Advertising-- Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against QuidelOrtho ("QuidelOrtho" or "the Company") and certain of its officers....

15 avr 2024
Historic Gift from Taneja Family Foundation Surpasses $120 Million in Total Contributions Toward Tampa General's Initiative to Transform Health Care Through Innovation and Technology
Tampa General Hospital (TGH) today celebrated more than $120 million in charitable contributions over a two-year period to advance its vision to transform health care through innovation. The latest gift toward the $120 million milestone came from the...

15 avr 2024
Cloud Migrations Boost Australian Microsoft Ecosystem
The acceleration of digital transformations and cloud implementations by Australian companies and government agencies is expanding the country's Microsoft cloud ecosystem, according to a new research report published today by Information Services...

More news about Covid-19 virus...


News published on and distributed by: